Literature DB >> 2871273

Non-A, non-B hepatitis after intravenous gammaglobulin.

O Weiland, L Mattsson, H Glaumann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871273     DOI: 10.1016/s0140-6736(86)91081-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Human Immunoglobulins for intravenous use and hepatitis C viral transmission.

Authors:  H B Slade
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

Review 2.  Side-effects of intravenous immune globulins.

Authors:  C Duhem; M A Dicato; F Ries
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

3.  Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-93.

Authors:  S Skull; A Kemp
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

Review 4.  Intravenous immune globulin in primary immunodeficiency.

Authors:  M Haeney
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

5.  Rapidly progressive hepatitis C in a patient with common variable immunodeficiency.

Authors:  R Sumazaki; T Matsubara; T Aoki; Y Nagai; M Shibasaki; H Takita
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti-HCV-positive intravenous immunoglobulins.

Authors:  F Dammacco; D Sansonno; A Beardsley; E J Gowans
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.